Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials

Negrier, C., Young, G., Abdul Karim, F., Collins, P. W., Hanabusa, H., Colberg, T., Goldman, B. and Walsh, C. E. 2016. Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials. Haemophilia 22 (4) , pp. 507-513. 10.1111/hae.12902

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Wiley-Blackwell
ISSN:	1351-8216
Date of First Compliant Deposit:	29 June 2017
Date of Acceptance:	1 March 2016
Last Modified:	18 Jul 2017 14:40
URI:	https://orca.cardiff.ac.uk/id/eprint/101906

Citation Data

Cited 20 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item